Callan Family Office LLC Invests $1.86 Million in U.S. Physical Therapy, Inc. $USPH

Callan Family Office LLC bought a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 27,106 shares of the company’s stock, valued at approximately $1,862,000.

A number of other institutional investors and hedge funds have also bought and sold shares of USPH. BlackRock Inc. bought a new position in U.S. Physical Therapy in the 2nd quarter valued at about $155,505,000. Vanguard Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 1,085,336 shares of the company’s stock worth $84,754,000 after acquiring an additional 15,712 shares during the period. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 6.5% in the first quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock valued at $62,729,000 after purchasing an additional 50,717 shares during the last quarter. Bank of America Corp DE grew its position in shares of U.S. Physical Therapy by 10.9% in the first quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after purchasing an additional 54,656 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of U.S. Physical Therapy by 3.2% in the first quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company’s stock valued at $38,035,000 after purchasing an additional 15,668 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH opened at $78.16 on Monday. U.S. Physical Therapy, Inc. has a 12-month low of $58.19 and a 12-month high of $93.50. The company’s 50 day moving average price is $73.59 and its two-hundred day moving average price is $73.83. The firm has a market cap of $1.17 billion, a PE ratio of 459.79, a PEG ratio of 2.15 and a beta of 1.13. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.81 earnings per share. Equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.95 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy’s dividend payout ratio (DPR) is 1,082.35%.

Insiders Place Their Bets

In related news, Director Peter Francis Minan acquired 492 shares of the company’s stock in a transaction on Monday, June 8th. The stock was purchased at an average cost of $63.14 per share, with a total value of $31,064.88. Following the acquisition, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

USPH has been the subject of several research reports. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Barrington Research increased their price objective on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $99.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.